Review
Parathyroid hormone for the treatment of osteoporosis: a systematic review
Ann Cranney, Alexandra Papaioannou, Nicole Zytaruk, David Hanley, Jonathan Adachi, David Goltzman, Timothy Murray, Anthony Hodsman and ; for the Clinical Guidelines Committee of Osteoporosis Canada
CMAJ July 04, 2006 175 (1) 52-59; DOI: https://doi.org/10.1503/cmaj.050929
Ann Cranney
Alexandra Papaioannou
Nicole Zytaruk
David Hanley
Jonathan Adachi
David Goltzman
Timothy Murray
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
CMAJ
Vol. 175, Issue 1
4 Jul 2006
Article tools
Parathyroid hormone for the treatment of osteoporosis: a systematic review
Ann Cranney, Alexandra Papaioannou, Nicole Zytaruk, David Hanley, Jonathan Adachi, David Goltzman, Timothy Murray, Anthony Hodsman
CMAJ Jul 2006, 175 (1) 52-59; DOI: 10.1503/cmaj.050929
Jump to section
Related Articles
Cited By...
- Prevention of osteoporosis-related fractures among postmenopausal women and older men
- Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation
- Management of osteoporosis in men: an update and case example
- ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB
- Parathyroid hormone reduces fractures in postmenopausal women with osteoporosis
- Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis.